The GLP-1 Revolution: Addressing India’s Unique Obesity Crisis
The Emergence of GLP-1 Generics in India As India grapples with its status as the global capital for diabetes, a wave of generic GLP-1 receptor agonists is entering the market this year, promising a new frontier in obesity management. These pharmaceutical interventions, once reserved for the ultra-wealthy, are now being integrated into everything from wellness…